-transparent.png){kind=logo}
Eight otherwise healthy male chronic marijuana smokers were hospitalized for a period of 30 days. Initially they received placebo, then a sustained dose of 210 milligrams of delta9-tetrahydrocannabinol (delta9-THC) per day for 18 days, followed by placebo. Lymphocyte responses to phytohemagglutinin were examined during each of these periods. Neither the daily ingestion of marijuana extract containing 210 milligrams of delta9-THC for 18 days nor the history of chronic marijuana smoking had a depressive effect on the lymphocyte responses of these subjects to phytohemagglutinin.
Related Publications
R J Lau, and
D G Tubergen, and
M Barr, and
E F Domino, and
N Benowitz, and
R T Jones
April 2009,
Psychopharmacology,
R J Lau, and
D G Tubergen, and
M Barr, and
E F Domino, and
N Benowitz, and
R T Jones
January 1974,
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association,
R J Lau, and
D G Tubergen, and
M Barr, and
E F Domino, and
N Benowitz, and
R T Jones
December 1978,
Toxicology and applied pharmacology,
R J Lau, and
D G Tubergen, and
M Barr, and
E F Domino, and
N Benowitz, and
R T Jones
March 1970,
Pediatrics,
R J Lau, and
D G Tubergen, and
M Barr, and
E F Domino, and
N Benowitz, and
R T Jones
March 1970,
Pediatrics,
R J Lau, and
D G Tubergen, and
M Barr, and
E F Domino, and
N Benowitz, and
R T Jones
January 1978,
Przeglad dermatologiczny,
R J Lau, and
D G Tubergen, and
M Barr, and
E F Domino, and
N Benowitz, and
R T Jones
March 1970,
Cancer research,
R J Lau, and
D G Tubergen, and
M Barr, and
E F Domino, and
N Benowitz, and
R T Jones
July 1977,
Science (New York, N.Y.),
R J Lau, and
D G Tubergen, and
M Barr, and
E F Domino, and
N Benowitz, and
R T Jones
January 1976,
The Tohoku journal of experimental medicine,
R J Lau, and
D G Tubergen, and
M Barr, and
E F Domino, and
N Benowitz, and
R T Jones
July 1983,
Polski tygodnik lekarski (Warsaw, Poland : 1960),
